Science
Mechanism of Action
This ingredient operates via a dual-action pathway: it inhibits the tyrosinase enzyme to disrupt melanin production and reduce hyperpigmentation, while also modulating skin matrix proteins to improve elastic fiber density. When integrated into ethosome delivery systems, it achieves superior transdermal penetration to reach the dermal layers where cellular repair is most effective.
Research
Clinical Evidence
Medium confidence1%
Key findings
- 01 In vitro and ex vivo assessments demonstrate significant wrinkle reduction and skin-lightening efficacy when delivered via ethosomes (US Patent 11452679B2).
- 02 Benchmarking against related caffeoyl-peptide conjugates indicates potent tyrosinase inhibition and radical scavenging even at concentrations as low as 10 ppm.
Transparency
Dusting Analysis
Because this peptide is effective at extremely low concentrations (parts per million), it is frequently used at 'label claim' levels that may not provide the full anti-aging benefits seen in 1-2% formulations.
The Formula
Formulation
Stability
Highly sensitive to premature oxidation; stability is best maintained through nano-encapsulation or liposomal delivery systems. It is unstable in acidic environments.
Synergies
- Ethosome delivery systems
- Lipids
- Non-acidic antioxidants
Conflicts
- Strong oxidizing agents
- Low pH environments (pH < 4.0)
- Proteolytic enzymes
- High thermal processing
Safety
Safety Profile
Derived from constituent amino acids and caffeic acid, both of which have well-established safety profiles in cosmetic applications. No significant irritation reported in patent testing.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A potent, multifunctional peptide ideal for precision brightening and structural repair, provided it is formulated within its stable pH window.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources